Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01726257 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

A NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Endologix.

Completed
Registry status
NA
Development phase
333
Enrollment target
20
Study locations

NCT01726257 is a NA study of Abdominal Aortic Aneurysm (AAA) that has completed, run by Endologix. The registered enrollment target is 333 participants, above the 78-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (327% higher). The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01726257, a NA study of Abdominal Aortic Aneurysm (AAA), has completed, sponsored by Endologix.

COMPLETED
Registry status
NA
Development phase
333 participants
Enrollment target
20
Study locations

Study Summary

The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).

Interventions

  • DEVICE Nellix System

Study Locations (20)

Florida

  • Baptist Hospital of Miami - Miami
  • Sacred Heart - Pensacola

Massachusetts

  • St. Elizabeth's Medical Center - Brighton
  • Bay State Hospital - Springfield

Ohio

  • Cleveland Clinic - Cleveland
  • Ohio Health Research Institute - Columbus

Arizona

  • Tucson Medical Center - Tucson

California

  • VA San Diego - San Diego

Connecticut

  • Yale University - New Haven

Delaware

  • Christiana Care Hospital - Newark

District of Columbia

  • MedStar Health Research Institute - Washington D.C.

Trial Details

FieldValue
Enrollment Target 333 participants
Start Date 2013-12
Est. Completion 2022-12
Phase NA

Sponsor

Endologix

17 total trials

What the Registry Record Tells You About NCT01726257

The ClinicalTrials.gov registry entry for NCT01726257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 78-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (327% higher). The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abdominal Aortic Aneurysm (AAA) appearing as the primary indexed condition, and to 1 intervention - of which Nellix System is the first listed.

NCT01726257 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Florida, Massachusetts, Ohio.

Frequently Asked Questions

What is clinical trial NCT01726257 about?

NCT01726257 is a clinical study titled "Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System". The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).

What is the current status of trial NCT01726257?

This trial is currently completed. It is a NA study. The enrollment target is 333 participants. The study started on 2013-12. Estimated completion is 2022-12.

What conditions does trial NCT01726257 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysm (AAA).

What interventions are being tested in trial NCT01726257?

The interventions under investigation include: Nellix System (DEVICE).

Who is sponsoring clinical trial NCT01726257?

This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01726257 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, Delaware, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Aortic Aneurysm (AAA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.